Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03446547
Title Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736) (ASTEROID)
Acronym ASTEROID
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vastra Gotaland Region
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Helsinki RECRUITING Helsinki Finland Details
Dept of Oncology RECRUITING Tampere Finland Details
Turku RECRUITING Turku Finland Details
Dept of Oncology RECRUITING Vaasa Finland Details
Dept of Oncology RECRUITING Oslo Norway Details
Dept of pulmonary medicine RECRUITING Tromsø Norway Details
Dept of Oncology RECRUITING Trondheim Norway Details
Ålesund RECRUITING Ålesund Norway Details
Dept of pulmonary medicine RECRUITING Gävle Sweden Details
Dept. of Oncology RECRUITING Göteborg Sweden Details
Dept of pulmonary medicine RECRUITING Linköping Sweden Details
Sunderbyn RECRUITING Luleå Sweden Details
Dept of pulmonary medicine RECRUITING Lund Sweden Details
Dept of Oncology RECRUITING Stockholm Sweden Details
Dept. of Oncology RECRUITING Umeå Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field